あなたの病院での多剤耐性グラム陰性桿菌の制御について:変革への旅
Controlling multidrug-resistant Gram-negative bacilli in your hospital: a transformational journey
L.S. Munoz-Price*
*Medical College of Wisconsin, WI, USA
Journal of Hospital Infection (2015) 89, 254-258
世界では過去 20 年間に多剤耐性グラム陰性菌が増大している。本稿では、カルバペネム耐性アシネトバクター・バウマニー(Acinetobacter baumannii)の制御を目的とした介入バンドルの実施、および効果的な制御に必要となる文化の変革に関して、著者の個人的な経験を述べる。
サマリー原文(英語)はこちら
同カテゴリの記事
Evaluation of fixed and variable hospital costs due to Clostridium difficile infection: institutional incentives and directions for future research
Sequential outbreaks of multidrug-resistant Acinetobacter baumannii in intensive care units of a tertiary referral hospital in Italy: combined molecular approach for epidemiological investigation
Five-year prospective study of tuberculin skin testing among new healthcare personnel at a university hospital in Thailand
Mandatory public reporting of healthcare-associated infections in developed countries: how can developing countries follow?
SARS-CoV-2 infection: advocacy for training and social distancing in healthcare settings
A. Gagneux-Brunon*, C. Pelissier, J. Gagnaire, S. Pillet, B. Pozzetto, E. Botelho-Nevers, P. Berthelot
*University Hospital of Saint-Etienne, France
Journal of Hospital Infection (2020) 106, 610-612
